reviewTop 10% cited
Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways
Journal of Pharmaceutical Sciences · 2007 · Vol. 97(8) · pp. 2924–2935
Bruce A. Kerwin✉(Amgen (United States))
Protein purification and stabilityViral Infectious Diseases and Gene Expression in InsectsDrug Solubulity and Delivery SystemsChemistrySorbitanPolysorbateOrganic chemistryFatty acidChromatographyHydrolysisFatty acid esterPulmonary surfactantBiochemistry
MeSH terms
Chemistry, PharmaceuticalOxidation-ReductionPolysorbatesProteinsSurface TensionSurface-Active AgentsMolecular Structure
Citations
774
FWCI
4.02
field-weighted impact
References
101
Percentile
95%
vs. same field & year
Citations per year
Cited by
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Nature Reviews Drug Discovery · 2014 · 1,597 citations
Protein aggregation: Pathways, induction factors and analysis
Journal of Pharmaceutical Sciences · 2008 · 879 citations
References
Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
Pharmaceutical Research · 1997 · 671 citations
Surface-Induced Denaturation of Proteins during Freezing and its Inhibition by Surfactants
Journal of Pharmaceutical Sciences · 1996 · 467 citations
Interactions of surfactants with polymers and proteins
Journal of Controlled Release · 1993 · 1,121 citations
Related articles
Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways
Journal of Pharmaceutical Sciences · 2007 · 774 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.